JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
- PMID: 12376563
- DOI: 10.1242/jcs.00082
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
Abstract
Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNK1, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes (BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (JunAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-Jun-phosphorylation-dependent and -independent mechanisms.
Similar articles
-
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576. J Bone Miner Res. 2012. PMID: 22337253
-
c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.Mol Cell Biol. 2004 Dec;24(24):10844-56. doi: 10.1128/MCB.24.24.10844-10856.2004. Mol Cell Biol. 2004. PMID: 15572687 Free PMC article.
-
AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun.Cell Death Differ. 2001 Aug;8(8):859-67. doi: 10.1038/sj.cdd.4400871. Cell Death Differ. 2001. PMID: 11526439
-
c-Jun and the transcriptional control of neuronal apoptosis.Biochem Pharmacol. 2000 Oct 15;60(8):1015-21. doi: 10.1016/s0006-2952(00)00372-5. Biochem Pharmacol. 2000. PMID: 11007936 Review.
-
Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology.Keio J Med. 2004 Jun;53(2):78-84. doi: 10.2302/kjm.53.78. Keio J Med. 2004. PMID: 15247511 Review.
Cited by
-
Acyloxyacyl hydrolase deficiency induces chronic inflammation and bone loss in male mice.J Mol Med (Berl). 2022 Nov;100(11):1599-1616. doi: 10.1007/s00109-022-02252-w. Epub 2022 Sep 16. J Mol Med (Berl). 2022. PMID: 36112153
-
Integrated single-cell and bulk RNA sequencing analysis reveal immune-related biomarkers in postmenopausal osteoporosis.Heliyon. 2024 Sep 17;10(18):e38022. doi: 10.1016/j.heliyon.2024.e38022. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39328516 Free PMC article.
-
Oxyresveratrol attenuates bone resorption by inhibiting the mitogen-activated protein kinase pathway in ovariectomized rats.Nutr Metab (Lond). 2024 Jan 19;21(1):7. doi: 10.1186/s12986-024-00781-4. Nutr Metab (Lond). 2024. PMID: 38243227 Free PMC article.
-
Osteoclasts: what do they do and how do they do it?Am J Pathol. 2007 Feb;170(2):427-35. doi: 10.2353/ajpath.2007.060834. Am J Pathol. 2007. PMID: 17255310 Free PMC article.
-
ThPOK Inhibits Osteoclast Formation Via NFATc1 Transcription and Function.JBMR Plus. 2022 Mar 14;6(4):e10613. doi: 10.1002/jbm4.10613. eCollection 2022 Apr. JBMR Plus. 2022. PMID: 35434449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
